Skip to main content
. Author manuscript; available in PMC: 2012 May 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Mar 2;252(3):259–267. doi: 10.1016/j.taap.2011.02.017

Table 2. Comparison of CYP expression between PXR-null and humanized PXR mice.

CYP hPXR Female PXR-null Female hPXR Male PXR-null Male
Cyp2b9 2.20 ± 0.53 4.98 ± 1.02 b* 1.00 ± 0.64 0.05 ± 0.03 d**
Cyp2b10 0.65 ± 0.14 0.79 ± 0.40 1.00 ± 0.56 0.36 ± 0.11
Cyp2c29 0.59 ± 0.27 0.63 ± 0.11 1.00 ± 0.28 1.71 ± 0.62
Cyp3a11 0.22 ± 0.05 0.25 ± 0.06 1.00 ± 0.44 0.23 ± 0.06
Cyp3a41 9.71 ± 1.75 22.78 ± 4.78 b* 1.00 ± 0.87 0.34 ± 0.24 d**

Data is expressed as relative data ± SEM

*

P-value < 0.05 and

**

p-value < 0.01; indicate statistical significance by one-way ANOVA followed by Dunnett's multiple comparison test.

a

Indicates significant difference between hPXR female and hPXR male.

b

Indicates significant difference between hPXR female and PXR-null female mice.

c

Indicates significant difference between hPXR male and PXR-null male mice.

d

Indicates significant difference between PXR-null female and PXR-null male mice.